2025 HCPCS Code C9146
Injection, mirvetuximab soravtansine-gynx, 1 mg
TAGS: mirvetuximab| Notice | HCPCS C9146 terminated on June 30, 2023. |
| Short Description | Inj, elahere, 1 mg |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | April 01, 2023 |
| HCPCS Action Effective Date | July 01, 2023 |
| HCPCS Pricing Indicator Code | 53 - Statute |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9156 - Flotufolastat f18, dia 1 mci
- C9157 - Inj, tofersen, 1 mg
- C9158 - Inj, uzedy, 1 mg
- C9159 - Inj, balfaxar, per i.u
- C9160 - Inj daxibotulinumtoxina-lanm
- C9161 - Inj, aflibercept hd, 1 mg
- C9162 - Inj, avacincaptad peg 0.1 mg
- C9163 - Inj talquetamab-tgvs 0.25 mg
- C9164 - Cantharidin top, applicator
- C9165 - Inj, elranatamab-bcmm, 1 mg
- C9166 - Injection, secukinumab
- C9167 - Inj, adzynma, 10 iu
- C9168 - Injection, mirikizumab-mrkz
- C9248 - Inj, clevidipine butyrate
- C9250 - Artiss fibrin sealant
- C9254 - Injection, lacosamide
- C9257 - Bevacizumab injection
- C9275 - Hexaminolevulinate hcl
- C9285 - Patch, lidocaine/tetracaine
- C9290 - Inj, bupivacaine liposome